PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal Carcinomatosis

NCT04000906 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Peritoneal Carcinomatosis

Interventions

DRUG: Nab paclitaxel
DRUG: Cisplatin

Sponsor

University Hospital, Geneva